Which of the following points should be included in the medication-teaching plan for a patient taking adalimumab (Humira)?
a) The medication is administered IM.
b) The medication is given at room temperature.
c) It is important to monitor for injection site reactions.
d) The patient should continue taking the medication if fever occurs.
Answer: c) It is important to monitor for injection site reactions.
If the answers is incorrect or not given, you can answer the above question in the comment box. If the answers is incorrect or not given, you can answer the above question in the comment box.